Types of Cancer

A prostate cancer screening test produced by San Diego-based Gen-Probe that could help doctors determine more accurately whether their patients need a repeat biopsy has been approved by the U.S. Food and Drug Administration.  

Laser light in combination with certain drugs – known as photodynamic therapy – can destroy cancer tumours, but is today used mostly to cure skin cancer. The reason that internal tumours are not treated with the method is that the technology does not ...  

Health experts said research funding for the disease is a fifth of the amount dedicated to fighting breast cancer – despite being just as deadly The Government’s prostate cancer policy has been branded a “national disgrace” by health experts who ...  

Canada's DiagnoCure Inc said it received U.S. regulatory approval for a prostate cancer test that may help avoid unnecessary biopsies, sending its shares to their highest in about 18 months. "We expect it (the approval) will increase our royalty revenues ...  

NEW YORK (Reuters Health) - Some men with prostate cancer may have increased risks of dying from causes other than the cancer itself, a new study finds. Researchers found that when men had their prostate cancer diagnosed after developing symptoms -- and ...  

Among the many types of cancer, prostate cancer is particularly fraught with uncertainty for patients and doctors: It's one of the most commonly diagnosed cancers in men, but treatment decisions are tricky because it's very hard to know how aggressive a ...  

A new prospective study of patients with Lynch syndrome - an inherited disorder of cancer susceptibility caused by mutations in specific DNA repair genes - provides the first strong evidence that people with Lynch syndrome face significantly increased risks of breast and pancreatic cancers. The study also provided new, clearer estimates of the risks of cancers already recognized to be associated with Lynch syndrome, including those of the...  

Dr. Howard Sandler, Radiation, Oncology, Prostate Cancer, Chairman of Radiation Oncology at Cedar Sinai Medical Center, discusses a new device for tracking prostate cancer during radiation sessions to reduce side effects. Prostate cancer is a secret for ...  

"Further clarification of the risk of breast cancer for women at various ages is needed to ... According to the National Cancer Institute, one to three percent of the population may have Lynch syndrome. In this study, researchers followed ...  

In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.  

Mecklenburg County Manager Harry Jones notified county commissioners and staff by email this morning that he is being treated for pancreatic cancer. The email did not address how that will affect his ability to continue working, chairman Harold Cogdell ...  

“What’s good for the heart may be good for the prostate,” according to a new study led by Dr. Jean-Alfred Thomas III a postdoctoral fellow of urology at the Duke Cancer Institute. The study, which suggests that “heart disease may be a risk factor ...  

Walnuts, of all things, appear to slow the growth of prostate cancer tumors–in mice at least. Researchers at the University of California at Davis have found that mice genetically programmed to develop prostate cancer had smaller, slower growing tumors if they consumed a diet containing walnuts. A U.C. Davis news release reports that when researchers at the school, working with colleagues at the USDA Western Regional Research Center in Albany...  

Just a month after Johns Island resident Calvin Cohen set his retirement from working as a lineman for Berkeley Electric Cooperative for more than 38 years, he found out he had prostate cancer. For years, at the recommendation of his urologist ...  

Canadian centre of excellence partners with US-based Molecular Insight Pharmaceuticals to manufacture a new radiopharmaceutical for clinical trials that will evaluate the potential to deliver targeted radiotherapy directly to metastatic prostate ...